NCT04256629 - A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

August 21, 2020

Study Completion Date

August 21, 2020

Conditions

Healthy Volunteers (Intended Indication: Chronic Kidney Disease)

Interventions

DRUG

Verinurad

Randomized subjects will receive oral dose of verinurad

DRUG

Placebo

Randomized subjects will receive oral dose of placebo

DRUG

Allopurinol

Randomized subjects will receive oral dose of allpurinol (Treatment A and B)

Trial Locations (1)

Research Site, Berlin